Pneumocystis jirovecii and Mycobacterium tuberculosis Pulmonary Coinfection in an HIV-Seronegative Patient: A Case Report and Literature Review
Shanchen Wei,Lianjun Lin
DOI: https://doi.org/10.2147/IDR.S370023
2022-07-30
Infection and Drug Resistance
Abstract:Shanchen Wei, Lianjun Lin Geriatric Department, Peking University First Hospital, Beijing, 100034, People's Republic of China Correspondence: Lianjun Lin, Geriatric Department, Peking University First Hospital, Xicheng District, Beijing, 100034, People's Republic of China, Email Background: Coinfection with Pneumocystis jirovecii and Mycobacterium tuberculosis is rare in HIV-seronegative patients. Because it is associated with unknown morbidity and a high mortality rate especially in patients with immunosuppression, health care practitioners should have a high index of suspicion when dealing with such patients. Case Presentation: A 66-year-old man with glucocorticoid therapy for 9 years had a fever after getting a cold and developed respiratory failure rapidly within 3 days. He was given trimethoprim-sulfamethoxazole empirically before Pneumocystis pneumonia (PCP) was confirmed with the presence of cysts in the sputum. Although there was a partial improvement of symptoms, an area of consolidation on the left upper lung lobe gradually enlarged. Bronchoscopy was performed 3 times and Mycobacterium tuberculosis infection was finally diagnosed. For 1 years, he was treated with standard antituberculosis agents, and his psychological well-being was managed using traditional Chinese medicine techniques. After 3 years of follow-up, his outcome was very good. Conclusion: HIV-seronegative patients on long-term glucocorticoid therapy in areas with a high incidence of Mycobacterium tuberculosis may be co-infected with Pneumocystis jirovecii . When opportunistic infections are suspected, diagnostic procedures including invasive ones should be performed as soon as possible and appropriate interventions need to be carried out promptly. Keywords: Mycobacterium tuberculosis , Pneumocystis jirovecii , PCP, HIV-seronegative, Immunosuppressed, corticosteroids Pneumocystis jirovecii and Mycobacterium tuberculosis are common opportunistic pulmonary pathogens in patients infected with human immunodeficiency virus (HIV). However, co-infection is extremely rare in HIV-seronegative patients; 1 while once occurred, it is severe and has a higher mortality rate. 2 Early diagnosis is difficult and delays in antibiotic treatment are more common in HIV-negative patients, which may lead to a poor prognosis. 3,4 Currently, there are no accurate diagnostic tools, so being aware of the possibility of coinfection and rapidly performing diagnostic procedures that may include invasive ones are key to improving clinical outcomes. A 66-year-old man presented and was admitted to the hospital with fever for 3 days and dyspnea for 1 day. The patient had been diagnosed with malignant pemphigus vulgaris and put on prednisolone, methylprednisolone and other immunosuppressive drugs for the past 9 years. On admission, he experienced respiratory failure. The absolute count of regulatory T lymphocytes was 156.67 cells/uL. The lactate dehydrogenase increased to 457 IU/L. The chest computed tomography (CT) scan revealed multiple flaky, fuzzy, and high-density opacities in both lungs (Figure 1A). The patient had been on steroids for a long time. He had obvious hypoxia and had never had any other respiratory symptoms or other infections. On respiratory examination, the patient did not have many rales in the lungs. The lung CT scan showed interstitial changes. PCP, usually treated with sulfonamides, was considered a possible etiology because of his immunocompromised state. Caspofungin is a good treatment of choice for Aspergillus infection, which could not be excluded. For other atypical pathogens, moxifloxacin should be added. Thus he was given trimethoprim-sulfamethoxazole (3 tablets, twice daily for 3 weeks), caspofungin (loading dose, 70mg infused over 1 hour; maintenance dose, 50 mg daily infused over 1 hour for 2 weeks), steroids, and moxifloxacin. Consequently, his respiratory function improved, and his body temperature dropped. PCP was confirmed 4 days later when cysts were found in the sputum ( Supplementary Material ). Figure 1 A chest CT scan of the 66-year-old man showing Pneumocystis jirovecii Pneumonia and Mycobacterium tuberculosis Infection. ( A ) A transverse chest CT scan obtained on the first day after admission showed multiple ground-glass opacities in both lungs (white arrow), and an area of consolidation in the left upper lung lobe (black arrow). ( B ) A follow-up chest CT scan obtained 1 month after admission showed the ground-glass opacities in both lungs were reduced (white arrow), but the left upper lobe consolidation was enlarged (black arrow). ( C ) A follow-up -Abstract Truncated-
pharmacology & pharmacy,infectious diseases